Paul van der Horst
Presidente presso MOLECURE S.A.
Profilo
Paul van der Horst is currently the Chairman-Supervisory Board at Molecure SA, the Director at Immunetune, and the Chief Business Officer at AgomAb Therapeutics NV.
Previously, he worked as the Director of Business Development & IR at Galapagos NV and as an Analyst at Van Lanschot Kempen NV (Broker).
He holds a doctorate degree from Erasmus University Rotterdam.
Posizioni attive di Paul van der Horst
| Società | Posizione | Inizio |
|---|---|---|
| MOLECURE S.A. | Presidente | - |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
| Immunetune | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Paul van der Horst
| Società | Posizione | Fine |
|---|---|---|
| GALAPAGOS NV | Public Communications Contact | 01/04/2021 |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Analyst-Equity | - |
Formazione di Paul van der Horst
| Erasmus University Rotterdam | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| MOLECURE S.A. | Health Technology |
| Aziende private | 3 |
|---|---|
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Finance |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
| Immunetune |
- Borsa valori
- Insiders
- Paul van der Horst
